Viewing Study NCT02216357


Ignite Creation Date: 2025-12-24 @ 7:08 PM
Ignite Modification Date: 2026-02-23 @ 1:10 AM
Study NCT ID: NCT02216357
Status: COMPLETED
Last Update Posted: 2017-05-15
First Post: 2014-08-12
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Trial to Determine the Safety of Oral Ifetroban in Patients With a History of Aspirin Exacerbated Respiratory Disease
Sponsor: Cumberland Pharmaceuticals
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: CPI-IFE-003
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators